Matches in Nanopublications for { ?s ?p "[As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP472660.RAUEsfbFq0InehursxI1q3iCXhSqZnJdkSY_6e-rQj0p8130_assertion description "[As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472660.RAUEsfbFq0InehursxI1q3iCXhSqZnJdkSY_6e-rQj0p8130_provenance.
- NP296650.RAboHmBdDRyWcBsvvIEpbGX8sbaOsC2AKqDorIk7NUgnI130_assertion description "[As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296650.RAboHmBdDRyWcBsvvIEpbGX8sbaOsC2AKqDorIk7NUgnI130_provenance.
- NP236763.RAOClTJPWqCp_eC4fUgPgqichZ5JnFXe4ZJtc7HmfX8Y0130_assertion description "[As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236763.RAOClTJPWqCp_eC4fUgPgqichZ5JnFXe4ZJtc7HmfX8Y0130_provenance.
- NP954542.RA_9Q8TsAJYgF2HiAi2nhBOhFYzVtjbHTgK5W399Yppc8130_assertion description "[As IAP proteins are typically aberrantly expressed in human cancers including hematological malignancies, they represent in principle promising targets for therapeutic interventions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954542.RA_9Q8TsAJYgF2HiAi2nhBOhFYzVtjbHTgK5W399Yppc8130_provenance.